Výsledky vyhledávání - "Mi Young Bahng"

Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil

Autor: Sangmin Choe, Sang Heon Cho, Sang Koo Lee, Won Seok Yang, Mi Young Bahng, Jai Won Chang, Yook Hwan Noh, Yong Soon Cho, Jong Lyul Ghim, Jung Sik Park, Soon Bae Kim, Hyeong Seok Lim, Kyun-Seop Bae

Publikováno v: The Journal of Clinical Pharmacology. 58:905-912

Udenafil is a phosphodiesterase-5 inhibitor used to treat erectile dysfunction. Although udenafil is not predominantly eliminated by the kidney, renal impairment can alter its secretion/transport pathways. Drug pharmacokinetics and safety must theref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f03824a0ff1f47503b0cc030f4c125
https://doi.org/10.1002/jcph.1095

Zobrazit plný text záznamu

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects

Autor: Kyung Sang Yu, Seo Hyun Yoon, Joo Youn Cho, Mi Young Bahng, Sojeong Yi, Dongseong Shin, In-Jin Jang, Seung-Hwan Lee

Publikováno v: Drug Design, Development and Therapy

Dongseong Shin,1 SeungHwan Lee,2 Sojeong Yi,2 Seo Hyun Yoon,2 Joo-Youn Cho,2 Mi Young Bahng,3 In-Jin Jang,2 Kyung-Sang Yu2 1Clinical Trials Center, Gachon University Gil Medical Center, Incheon, 2Department of Clinical Pharmacology and Therapeutics,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec6392520b19c2258a8189888c55c81
http://europepmc.org/articles/PMC5354528

Zobrazit plný text záznamu

The Effect of Age on the Pharmacokinetics of Udenafil in Healthy Subjects

Autor: Jin Ah Jung, Mi Young Bahng, Jae-Gook Shin, Hyang-Ki Choi, Doo-Yeoun Cho, Ji-Hong Shon, Eun Young Kim, Chang Woo Yeo

Publikováno v: The Journal of Clinical Pharmacology. 56:1372-1377

Udenafil, a cyclic guanosine monophosphate-specific phosphodiesterase type 5 inhibitor, has been developed to treat erectile dysfunction. We evaluated the effect of age on the pharmacokinetics and tolerability of udenafil. A single-center, open-label

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::44692b26f21c835ffd2e425e74978f80
https://doi.org/10.1002/jcph.739

Zobrazit plný text záznamu

Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment

Autor: Dong Hoon Shin, Yong Jin Jung, Anhye Kim, In-Jin Jang, Joo Youn Cho, Mi Young Bahng, Jongtae Lee

Publikováno v: British Journal of Clinical Pharmacology. 82:389-398

AIMS The aim of this study was to develop a population pharmacokinetic (PK) model of udenafil and its active metabolite, DA-8164, in healthy subjects and patients with hepatic impairment (HI) and to estimate the optimal dosing recommendations for pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::56ff0e6fe46f4495118c6df847090e11
https://doi.org/10.1111/bcp.12977

Zobrazit plný text záznamu

Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

Autor: Joo Youn Cho, Mi Young Bahng, In-Jin Jang, Min Kyu Park, Seo Hyun Yoon, Tae Eun Kim, Kyoung Soo Lim, Sang Heon Cho, Kyung Sang Yu, Namyi Gu

Publikováno v: Drug Design, Development and Therapy

Namyi Gu,1,3,* Min Kyu Park,1,4,* Tae-Eun Kim,1,5 Mi Young Bahng,2 Kyoung Soo Lim,1 Sang-Heon Cho,1 Seo Hyun Yoon,1 Joo-Youn Cho,1 In-Jin Jang,1 Kyung-Sang Yu1 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a60544d63748c1caf0af1af78709852
http://europepmc.org/articles/PMC4199987

Zobrazit plný text záznamu

Pharmacokinetic Comparison of 2 Fixed-Dose Combination Tablets of Amlodipine and Valsartan in Healthy Male Korean Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Study

Autor: Hankil Son, Mijeong Son, Donghwan Lee, Kyungsoo Park, Hyerang Roh, Yukyung Kim, Mi Young Bahng, Dongwoo Chae

Publikováno v: Clinical Therapeutics. 35:934-940

Background Amlodipine and valsartan have different mechanisms of action, and it is known that the combination therapy with the 2 drugs increases treatment effects compared with the monotherapy with each drug. A fixed-dose combination (FDC) drug is a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6832f11aedb1da29ebd26fe1825acab9
https://doi.org/10.1016/j.clinthera.2013.05.021

Zobrazit plný text záznamu

The Effect of Age on the Pharmacokinetics of Udenafil in Healthy Subjects

Autor: Hyang-Ki, Choi, Jin Ah, Jung, Jihong, Shon, Mi Young, Bahng, Doo-Yeoun, Cho, Chang Woo, Yeo, Eun-Young, Kim, Jae-Gook, Shin

Publikováno v: Journal of clinical pharmacology. 56(11)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::313a9cb24f65136e4184e72a864a6dca
https://pubmed.ncbi.nlm.nih.gov/27006150

Zobrazit plný text záznamu

Population pharmacokinetic analysis to recommend the optimal dose of udenafil in patients with mild and moderate hepatic impairment

Autor: Anhye, Kim, Jongtae, Lee, Donghoon, Shin, Yong Jin, Jung, Mi Young, Bahng, Joo-Youn, Cho, In-Jin, Jang

Publikováno v: British journal of clinical pharmacology. 82(2)

The aim of this study was to develop a population pharmacokinetic (PK) model of udenafil and its active metabolite, DA-8164, in healthy subjects and patients with hepatic impairment (HI) and to estimate the optimal dosing recommendations for patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b7b7170b091b6daf269e27f385187fe7
https://pubmed.ncbi.nlm.nih.gov/27084997

Zobrazit plný text záznamu

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects

Autor: Jin Ah Jung, Wooseong Huh, Jae-Wook Ko, Jung-Ryul Kim, Soo-Yun Lee, Mi Young Bahng

Publikováno v: Drug Design, Development and Therapy

Soo-Yun Lee,1 Jung-Ryul Kim,2,3 Jin Ah Jung,4 Wooseong Huh,2,5 Mi Young Bahng,6 Jae-Wook Ko1,2 1Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; 2Department of Clinical Pharmacology and Therapeu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a61cf11f542c53149ae69fc4acd749
https://doi.org/10.2147/dddt.s82820

Zobrazit plný text záznamu

Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers

Autor: Hyeong-Seok Lim, Yo Han Kim, Hee Youn Choi, Mi Young Bahng, Kyun-Seop Bae, Shi Hyang Lee, Hae Sun Jeon

Publikováno v: Drug Design, Development and Therapy

Yo Han Kim,1 Hee Youn Choi,1 Shi Hyang Lee,1 Hae Sun Jeon,1 Hyeong-Seok Lim,1 Mi Young Bahng,2 Kyun-Seop Bae1 1Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, College of Medicine, University of Ulsan, 2Clinical Development

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081b8e996c9e33bfcdb48b0fd4ec3a0f
https://doi.org/10.2147/dddt.s78713

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání